Cargando…
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
PIK3CA mutations are amongst the most prevalent somatic mutations in cancer and are associated with resistance to first-line treatment along with low survival rates in a variety of malignancies. There is evidence that patients carrying PIK3CA mutations may benefit from treatment with acetylsalicylic...
Autores principales: | Hall, Daniella C. N., Benndorf, Ralf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250486/ https://www.ncbi.nlm.nih.gov/pubmed/35780223 http://dx.doi.org/10.1007/s00018-022-04430-y |
Ejemplares similares
-
Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition
por: Boku, Shogen, et al.
Publicado: (2020) -
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin
por: Turturro, Sanja B., et al.
Publicado: (2016) -
PIK3CA mutation and colorectal cancer precision medicine
por: Hamada, Tsuyoshi, et al.
Publicado: (2017) -
PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014) -
Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors
por: Gebauer, Leonie, et al.
Publicado: (2021)